Anthrax vs. the Cure
By AAN Staff
september 25, 2003 07:47 pm
During the height of the anthrax scare two years
ago, Cipro was widely seen as a silver
bullet against the fatal illness, and Bayer
Pharmaceutical vowed to keep the nation
armed. Now a class action lawsuit against Bayer
claims the antibiotic left many users with a
variety of debilitating ailments, including
severe joint pain, tendinitis and muscle ache, severe
anxiety and panic attacks, insomnia and depression.
Although those claims are open to dispute,
Patrick Rucker reports that the decision to
widely use Cipro against the anthrax attacks “now
seems to have been hasty and made without a
full appreciation of the consequences.”